National Biomedical Resource Indigenization Consortium
- 14 May 2020
- 2 min read
Why in News
Recently, the Department of Biotechnology (DBT) has launched a National Biomedical Resource Indigenization Consortium (NBRIC) to drive indigenous innovation focused on developing reagents (used in chemical reactions), diagnostics, vaccines and therapeutics for Covid-19.
- It is a Public Private Partnership (PPP) hosted and led by the Centre for Cellular and Molecular Platforms (C-CAMP).
- It is a ‘Make in India’ initiative for biomedical research and innovative products, towards promoting import substitution and exports.
- It aims to establish a nation-wide collaborative platform for convergence of research, product resources and services towards developing reagents, diagnostics, vaccines, and therapeutics across India.
- It identifies providers/manufacturing enterprises of crucial bio-medical resources and connects them with policy makers as well as with other stakeholders from public and private sectors.
Centre for Cellular and Molecular Platforms
- Centre for Cellular and Molecular Platforms (C-CAMP) is one of the centers for technology-based innovation and entrepreneurship in the field of life sciences under the Department of Biotechnology (DBT).
- It intends to develop state-of-the-art technologies and to provide training on these technologies to academia and industry.